The Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new legislation effective June 16, 2025, to strengthen post-market surveillance requirements for medical devices, including digital mental health technologies, emphasizing the need for improved adverse event reporting and safety measures.
View full story…
New MHRA Legislation Enhances Post-Market Surveillance for Medical Devices
